搜尋結果
GSK’s Withdrawn Blood Cancer Drug Poised for Comeback
Bloomberg· 3 日前GSK Plc said a blood cancer drug it had to pull from the market after a trial failure has shown ...
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 7 日前A recent study in the New England Journal of Medicine grabbed the attention of the medical ...